Merck & Co., Inc. (MRK)

USD 98.34

(-1.72%)

Revenue Summary of Merck & Co., Inc.

  • Merck & Co., Inc.'s latest annual revenue in 2023 was 60.11 Billion USD , up 1.4% from previous year.
  • Merck & Co., Inc.'s latest quarterly revenue in 2024 Q3 was 16.65 Billion USD , up 3.1% from previous quarter.
  • Merck & Co., Inc. reported a annual revenue of 59.28 Billion USD in annual revenue 2022, up 21.72% from previous year.
  • Merck & Co., Inc. reported a annual revenue of 48.7 Billion USD in annual revenue 2021, up 17.31% from previous year.
  • Merck & Co., Inc. reported a quarterly revenue of 15.77 Billion USD for 2024 Q1, up 7.83% from previous quarter.
  • Merck & Co., Inc. reported a quarterly revenue of 16.15 Billion USD for 2024 Q2, up 2.42% from previous quarter.

Annual Revenue Chart of Merck & Co., Inc. (2023 - 1989)

Historical Annual Revenue of Merck & Co., Inc. (2023 - 1989)

Year Revenue Revenue Growth
2023 60.11 Billion USD 1.4%
2022 59.28 Billion USD 21.72%
2021 48.7 Billion USD 17.31%
2020 41.51 Billion USD -11.36%
2019 46.84 Billion USD 10.75%
2018 42.29 Billion USD 5.41%
2017 40.12 Billion USD 0.79%
2016 39.8 Billion USD 0.78%
2015 39.49 Billion USD -6.48%
2014 42.23 Billion USD -4.08%
2013 44.03 Billion USD -6.84%
2012 47.26 Billion USD -1.62%
2011 48.04 Billion USD 4.48%
2010 45.98 Billion USD 67.66%
2009 27.42 Billion USD 15.0%
2008 23.85 Billion USD -1.44%
2007 24.19 Billion USD 6.9%
2006 22.63 Billion USD 2.84%
2005 22.01 Billion USD -4.04%
2004 22.93 Billion USD 2.01%
2003 22.48 Billion USD -56.58%
2002 51.79 Billion USD 8.54%
2001 47.71 Billion USD 18.22%
2000 40.36 Billion USD 23.38%
1999 32.71 Billion USD 21.62%
1998 26.89 Billion USD 13.8%
1997 23.63 Billion USD 19.21%
1996 19.82 Billion USD 18.87%
1995 16.68 Billion USD 11.43%
1994 14.96 Billion USD 42.59%
1993 10.49 Billion USD 8.65%
1992 9.66 Billion USD 12.32%
1991 8.6 Billion USD 12.14%
1990 7.67 Billion USD 17.11%
1989 6.55 Billion USD 10.29%

Peer Revenue Comparison of Merck & Co., Inc.

Name Revenue Revenue Difference
AbbVie Inc. 54.31 Billion USD -10.672%
Bristol-Myers Squibb Company 45 Billion USD -33.571%
Bristol-Myers Squibb Company Ce 45 Billion USD -33.571%
Johnson & Johnson 85.15 Billion USD 29.409%
Eli Lilly and Company 34.12 Billion USD -76.166%
Novartis AG 46.66 Billion USD -28.836%
Organon & Co. 6.26 Billion USD -859.844%
Pfizer Inc. 58.49 Billion USD -2.768%